Last edition
News about Global Pharma
Samsung Biologics Highlights 2025 Outlook at J.P. Morgan Healthcare Conference
Samsung Biologics announced its latest business achievements and 2025 outlook at the 43rd J.P. Morgan Healthcare Conference, which was held in San Francisco between January 13-16.
Global Pharma | 17/01/2025 | By Manvi | 755
Alembic Pharmaceuticals Announces USFDA Final Approval for Brexpiprazole Tablets
Alembic Pharmaceuticals has received USFDA final approval for its ANDA of Brexpiprazole Tablets in multiple strengths, a therapeutic equivalent to Otsuka's Rexulti, used for major depressive disorder and schizophrenia.
Global Pharma | 17/01/2025 | By Manvi | 255
Innovent and ASK Pharma Announce NMPA Approval of Limertinib for Lung Cancer
Innovent Biologics and Jiangsu Aosaikang Pharmaceutical announced that China's NMPA has approved the New Drug Application (NDA) of limertinib for treating adult patients with locally advanced or metastatic EGFR T790M-mutated non-small cell lung cancer (NSCLC).
Global Pharma | 17/01/2025 | By Manvi | 264
Avicanna and Vectura Fertin Pharma are collaborating to establish a joint Scientific and Medical Affairs Committee focused on improving the understanding of medical cannabis access and applications in Canada.
Global Pharma | 17/01/2025 | By Abha | 425
Biofidelity and CellCarta Announce Partnership to Enhance NSCLC Clinical Trials with Aspyre Lung
Aspyre Lung simplifies the detection of established non-small cell lung cancer (NSCLC) biomarkers by analysing both DNA and RNA from tissue and blood using a streamlined four-step workflow.
Global Pharma | 17/01/2025 | By Abha | 323
Sun Pharma to Acquire Canada-based Clinical-stage Biotechnology Company Antibe Therapeutics
Sun Pharmaceutical Industries Ltd. is set to acquire Canada-based Antibe Therapeutics, a clinical-stage biotech firm focused on pain and inflammation drugs, through its subsidiary TARO Pharmaceuticals. The indicative period for completion of the acquisition is before March 7, 2025.
Global Pharma | 16/01/2025 | By Manvi | 751
ErlySign Secures INR 16 Crore in Pre-Series A Funding from Investor Ashish Kacholia
The investment, advised by DerivativeSaint—a boutique private equity and venture capital advisory firm—marks a pivotal moment for CURO Biosciences.
Global Pharma | 16/01/2025 | By Aishwarya | 545
Alembic Pharmaceuticals Gets USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Depakote Sprinkle Capsules, 125 mg, of AbbVie Inc.
Global Pharma | 16/01/2025 | By Aishwarya | 377
Piramal Pharma to Operate its Digwal Facility on Biomass Briquettes to Promote Sustainability
This achievement marks a substantial step toward Piramal's sustainability goal to reduce Scope 1 and 2 greenhouse gas (GHG) emissions by 42 percent by 2030.
Global Pharma | 16/01/2025 | By Aishwarya | 895
DFE Pharma Expands DPI Expertise at Hyderabad C2F Center to Boost Respiratory Drug Development
The C2F center supports global pharmaceutical companies to bring their products to market faster and more efficiently.
Global Pharma | 15/01/2025 | By Abha | 776
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy